The global health burden of chronic kidney disease is rapidly rising, and chronic kidney
disease is an important risk factor for cerebrovascular disease. Proposed underlying …

Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Background: Patients with end-stage kidney disease (ESKD) on dialysis were excluded from
clinical trials of direct oral anticoagulants for atrial fibrillation (AF). Recent data have raised …

Patients with chronic kidney disease (CKD) are predisposed to heart rhythm disorders,
including atrial fibrillation (AF)/atrial flutter, supraventricular tachycardias, ventricular …

Background The most common type of arrhythmia in the USA and in European countries is
atrial fibrillation (AF). The prevalence of AF is increasing worldwide with advances in …

Background Patients on long-term dialysis are at increased risk of bleeding. Although oral
anticoagulants (OACs) are recommended for atrial fibrillation (AF) to reduce the risk of …

Cardiovascular diseases such as coronary artery disease, congestive heart failure,
arrhythmias and sudden cardiac death represent main causes of morbidity and mortality in …

It is unclear whether warfarin is protective or harmful in patients with ESRD and atrial
fibrillation. This state of equipoise raises the question of whether alternative anticoagulants …

Context New-onset atrial fibrillation (AF) has been reported in 6% to 20% of patients with
severe sepsis. Chronic AF is a known risk factor for stroke and death, but the clinical …

Background The reported incidence, prevalence and outcomes of atrial fibrillation (AF) in
patients with end-stage renal disease (ESRD) are variable. The risks and benefits of …